Richard Storer

8.6k total citations · 4 hit papers
136 papers, 6.2k citations indexed

About

Richard Storer is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Richard Storer has authored 136 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 72 papers in Organic Chemistry and 43 papers in Infectious Diseases. Recurrent topics in Richard Storer's work include HIV/AIDS drug development and treatment (41 papers), Biochemical and Molecular Research (22 papers) and Chemical Synthesis and Analysis (21 papers). Richard Storer is often cited by papers focused on HIV/AIDS drug development and treatment (41 papers), Biochemical and Molecular Research (22 papers) and Chemical Synthesis and Analysis (21 papers). Richard Storer collaborates with scholars based in United Kingdom, United States and France. Richard Storer's co-authors include David W. C. MacMillan, Diane E. Carrera, Yike Ni, Lyn H. Jones, C. Aciro, Steven V. Ley, Francis X. Wilson, Philip S. Jackson, Andrew G. Leach and Darren J. Dixon and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Richard Storer

129 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enantioselective Organocatalytic Reductive Amination

2005 645 citations Richard Storer et al. profile →
Multi-step organic synthesis using solid-supported reagents and scavengers: a new paradigm in chemical library generation

2000 592 citations Richard Storer et al. profile →
Put a ring on it: application of small aliphatic rings in medicinal chemistry

2021 306 citations Paolo Di Fruscia, Simon C. C. Lucas et al. RSC Medicinal Chemistry profile →
Physiology of Hyperuricemia and Urate-Lowering Treatments

2018 222 citations Richard Storer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Storer United Kingdom	33	3.9k	2.7k	837	832	444	136	6.2k
Malcolm MacCoss United States	36	3.4k 0.9×	2.3k 0.9×	439 0.5×	820 1.0×	554 1.2×	136	6.4k
Mats Larhed Sweden	55	7.1k 1.8×	2.4k 0.9×	1.5k 1.8×	353 0.4×	217 0.5×	238	9.3k
Helmut Vorbrüggen Germany	32	3.6k 0.9×	2.7k 1.0×	393 0.5×	597 0.7×	245 0.6×	116	5.4k
Edward E. Knaus Canada	38	3.7k 1.0×	1.6k 0.6×	214 0.3×	405 0.5×	278 0.6×	339	6.1k
Liangren Zhang China	39	2.4k 0.6×	2.8k 1.0×	268 0.3×	239 0.3×	200 0.5×	236	6.2k
George L. Trainor United States	37	1.6k 0.4×	2.3k 0.8×	170 0.2×	413 0.5×	179 0.4×	83	4.5k
Dharmarajan Sriram India	54	10.0k 2.6×	4.6k 1.7×	465 0.6×	2.4k 2.9×	704 1.6×	440	13.5k
Kevin T. Chapman United States	30	2.8k 0.7×	3.5k 1.3×	316 0.4×	178 0.2×	313 0.7×	82	6.1k
Romano Silvestri Italy	39	3.3k 0.9×	1.6k 0.6×	140 0.2×	793 1.0×	312 0.7×	191	5.5k
Jean d’Angelo France	35	2.8k 0.7×	1.5k 0.5×	511 0.6×	348 0.4×	78 0.2×	139	4.9k

Countries citing papers authored by Richard Storer

Since Specialization

Citations

This map shows the geographic impact of Richard Storer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Storer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Storer more than expected).

Fields of papers citing papers by Richard Storer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Storer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Storer. The network helps show where Richard Storer may publish in the future.

Co-authorship network of co-authors of Richard Storer

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Storer. A scholar is included among the top collaborators of Richard Storer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Storer. Richard Storer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boerth, Jeffrey A., Marianne Schimpl, Simon C. C. Lucas, et al.. (2025). Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain Binders. ACS Medicinal Chemistry Letters. 16(6). 1073–1079.

Beale, Andrew D., Iacovos N. Michaelides, Sew‐Yeu Peak‐Chew, et al.. (2025). Development of compounds for targeted degradation of mammalian cryptochrome proteins.. PubMed. 380(1918). 20230342–20230342. 2 indexed citations

Ashraf, Sajda, et al.. (2024). Hit me with your best shot: Integrated hit discovery for the next generation of drug targets. Drug Discovery Today. 29(10). 104143–104143. 6 indexed citations

Tallant, C., Katarzyna B. Leszczyńska, Rachel L. Grimley, et al.. (2022). Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains. ACS Chemical Biology. 17(10). 2753–2768. 13 indexed citations

Lucas, Simon C. C., Ulf Börjesson, Mark J. Bostock, et al.. (2022). Fragment screening at AstraZeneca: developing the next generation biophysics fragment set. RSC Medicinal Chemistry. 13(9). 1052–1057. 8 indexed citations

Donald, James R., James D. Firth, Claudia De Fusco, et al.. (2021). Synthesis and functionalisation of a bifunctional normorphan 3D building block for medicinal chemistry. Tetrahedron. 83. 131961–131961. 5 indexed citations

Fruscia, Paolo Di, Fredrik Edfeldt, Igor L. Shamovsky, et al.. (2021). Fragment-Based Discovery of Novel Allosteric MEK1 Binders. ACS Medicinal Chemistry Letters. 12(2). 302–308. 11 indexed citations

Collie, Gavin W., Iacovos N. Michaelides, Kevin J. Embrey, et al.. (2020). Structural Basis for Targeting the Folded P-Loop Conformation of c-MET. ACS Medicinal Chemistry Letters. 12(1). 162–167. 15 indexed citations

Albrow, Victoria E., Rachel L. Grimley, Colin R. Rose, et al.. (2016). Design and development of histone deacetylase (HDAC) chemical probes for cell-based profiling. Molecular BioSystems. 12(6). 1781–1789. 10 indexed citations

10.

Storer, Richard, et al.. (2016). A semi-quantitative translational pharmacology analysis to understand the relationship between in vitro ENT1 inhibition and the clinical incidence of dyspnoea and bronchospasm. Toxicology and Applied Pharmacology. 317. 41–50. 13 indexed citations

11.

Bagal, Sharan K., et al.. (2014). Recent progress in sodium channel modulators for pain. Bioorganic & Medicinal Chemistry Letters. 24(16). 3690–3699. 124 indexed citations

12.

Muratore, Michael E., Lei Shi, Adam W. Pilling, Richard Storer, & Darren J. Dixon. (2012). Exploiting a novel size exclusion phenomenon for enantioselective acid/base cascade catalysis. Chemical Communications. 48(51). 6351–6351. 32 indexed citations

13.

Loddo, Roberta, Sophia G. Antimisiaris, Ulrike Sauermann, et al.. (2011). Topical Nonnucleoside Reverse Transcriptase Inhibitor MC 1220 Partially Prevents Vaginal RT-SHIV Infection of Macaques. AIDS Research and Human Retroviruses. 27(9). 933–943. 16 indexed citations

14.

Storer, Richard, C. Aciro, & Lyn H. Jones. (2011). Squaramides: physical properties, synthesis and applications. Chemical Society Reviews. 40(5). 2330–2330. 471 indexed citations

15.

Roberts, Lee R., Paul V. Fish, Richard Storer, & Gavin A. Whitlock. (2009). 6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective α1A adrenoceptor partial agonists. Bioorganic & Medicinal Chemistry Letters. 19(11). 3113–3117. 13 indexed citations

16.

Damont, Annelaure, et al.. (2007). Synthesis of 1′-C-Fluoromethyladenosine. Nucleosides Nucleotides & Nucleic Acids. 26(10-12). 1431–1434. 7 indexed citations

17.

Roy, Caroline, et al.. (2002). Synthesis and structure–activity relationship of novel aminotetralin derivatives with high μ selective opioid affinity. Bioorganic & Medicinal Chemistry Letters. 12(21). 3141–3143. 7 indexed citations

18.

Coe, Diane M. & Richard Storer. (1998). Solution-phase combinatorial chemistry. Molecular Diversity. 4(1). 31–38. 7 indexed citations

19.

Mahmoudian, Mahmoud, B S Baines, Richard Hale, et al.. (1993). Enzymatic production of optically pure (2′R-cis)-2′-deoxy-3′-thiacytidine (3TC, lamivudine): A potent anti-HIV agent. Enzyme and Microbial Technology. 15(9). 749–755. 40 indexed citations

20.

Humber, David C., N. Cammack, Jonathan A. Coates, et al.. (1992). Penicillin derived C2-symmetric dimers as novel inhibitors of HIV-1 proteinase. Journal of Medicinal Chemistry. 35(16). 3080–3081. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact